Chris Vazquez - Nov 10, 2025 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Chief Accounting Officer
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Chris Vazquez
Stock symbol
BDSX
Transactions as of
Nov 10, 2025
Transactions value $
-$99
Form type
4
Date filed
11/13/2025, 04:54 PM
Previous filing
Aug 14, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vazquez Chris Chief Accounting Officer 919 WEST DILLON RD, LOUISVILLE /s/ Robin H. Cowie as Attorney-in-Fact for Chris Vazquez 2025-11-13 0001980594

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +31 +3.38% 949 Nov 10, 2025 Direct F1, F2
transaction BDSX Common Stock Sale -$99 -13 -1.37% $7.62 936 Nov 10, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Options Exercise $0 -31 -51.67% $0.00 29 Nov 10, 2025 Common Stock 31 Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.
F2 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F3 These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
F4 These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.